Sign in

Gregers Wegener

@wegener.bsky.social
96 followers 94 following 2 posts

Professor, Aarhus University Editor-in-chief @actaneuropsych.bsky.social

PostsRepliesMedia
Gregers Wegener @wegener.bsky.social · 08/07/2025
When political agendas try to reshape science, integrity is the first casualty. Assigning the power to “correct” scientific information to political appointees is not the way forward. #ScienceIntegrity #ScientificFreedom #ResearchEthics #OpenScience
doi.org
Subversion of publishing comes to a boil: is it time to lance it? | The British Journal of Psychiatry | Cambridge Core
Subversion of publishing comes to a boil: is it time to lance it?
010
Gregers Wegener @wegener.bsky.social · 24/04/2025
Please read this important Editorial from BJPsych, written by 22 Journal Editors of Scientific Psychiatic Journals. doi.org/10.1192/bjp.... @actaneuropsych.bsky.social #MentalHealthResearch #ScienceIntegrity #AcademicFreedom #MentalHealthPolicy #ScientificTruth
doi.org
Truthful communication of mental science: pledge to our patients and profession | The British Journal of Psychiatry | Cambridge Core
Truthful communication of mental science: pledge to our patients and profession
051
Reposted by Gregers Wegener
Acta Neuropsychiatrica @actaneuropsych.bsky.social · 04/04/2025
🧠 GLP-1 Receptor Agonists: A new frontier in mental health treatment? 📚 This systematic review from McIntyre group explores whether GLP-1 receptor agonists (GLP-1 RAs) influence molecular and cellular systems implicated in neurogenesis and...
121
Reposted by Gregers Wegener
Acta Neuropsychiatrica @actaneuropsych.bsky.social · 24/01/2025
📢 More interesting results on GLP-1 agonist therapy! The recent preclinical data published in Acta Neuropsychiatrica highlights the importance of guiding #GLP-1agonist treatments with robust evidence. 🌟 Key Findings ⬇️ @altmetric.com @cambridgeup.bsky.social
123
Reposted by Gregers Wegener
Acta Neuropsychiatrica @actaneuropsych.bsky.social · 10/01/2025
💻 Generative AI in mental health is a rapidly moving field! 📚 This study recently published in Acta Neuropsychiatrica aimed to shed light on the use of generative AI in psychiatry and #mentalhealth settings, by systematically reviewing the literature (40 studies examined!).⬇
122
Reposted by Gregers Wegener
Acta Neuropsychiatrica @actaneuropsych.bsky.social · 02/01/2025
🌟Neuropsychiatric disorders 🧠 are frequently associated with metabolic comorbidities. The contributions of our most recent Special Issue present a diverse array of studies that illustrate the breadth of Metabolic Neuropsychiatry. Check it out 🧵: www.cambridge.org/core/journal...
122
Reposted by Gregers Wegener
OpenBehavior @openbehavior.bsky.social · 27/12/2024
MoSeq and Keypoint MoSeq, tools for analyzing behavioral "syllables”, were the top video related tools on the website in 2044. #neuroscience #videoanalysis #opensoftware edspace.american.edu/openbehavior...
edspace.american.edu
MoSeq
Visit the post for more.
152
Reposted by Gregers Wegener
Acta Neuropsychiatrica @actaneuropsych.bsky.social · 25/12/2024
Wishes of a beautiful holiday season!
011
Reposted by Gregers Wegener
Acta Neuropsychiatrica @actaneuropsych.bsky.social · 18/12/2024
This new study from Dr. Harkin’s group aimed to investigate mRNA expression of the kynurenine pathway (KP)enzymes in medicated patients with depression, and after ECT therapy. 🧬 Changes in expression of target KP enzymes correlated with changes in mood, w/ treatment response + remission. 📈
112
Reposted by Gregers Wegener
Acta Neuropsychiatrica @actaneuropsych.bsky.social · 11/12/2024
🧠 Highlights from Acta Neuropsychiatrica: Top Papers of 2024 Curious about what’s trending in the journal? Discover the most talked-about research of 2024, showcasing what your peers are reading, citing, and discussing. Check what is shaping the future of Psychiatry and stay connected. 🧵
203
Reposted by Gregers Wegener
Micah G. Allen @micahgallen.com · 02/12/2024
Would you like to see @biorxivpreprint.bsky.social add a share to blue sky button?! I know I would! Share this post to let @richardsever.bsky.social @erictopol.bsky.social and others at bioarxiv know!
A screenshot of a paper on bioarxiv illustrating the lack of blue sky share button!
9385196
Reposted by Gregers Wegener
Acta Neuropsychiatrica @actaneuropsych.bsky.social · 06/12/2024
In a recent study, Fukumori et al. explored whether combining psychotherapy with medication is more effective than psychotherapy alone for treating depression. The findings are insightful: 👇 #Psychology #Psychiatry #MentalHealth #DepressionTreatment #CBT #Psychotherapy @altmetric.com
141
Reposted by Gregers Wegener
Acta Neuropsychiatrica @actaneuropsych.bsky.social · 28/11/2024
🧠 Did you know there are still no drugs clearly defined for the treatment of borderline personality disorder? 🧪 In this open-label randomized controlled study, Rothman et al. assessed the efficacy, safety, and tolerability of aripiprazole. ↘️🧵
122
Reposted by Gregers Wegener
Alex Kwan @alexkwan.bsky.social · 19/11/2024
There are many nuances regarding the structural neural plasticity associated with antidepressant drugs. 💊🧠 We share our thoughts here in a Nature Reviews Neuroscience article, led by Clara Liao with co-authors from Conor Liston’s lab at Weill Cornell. www.nature.com/articles/s41...
Review article on neural plasticity and antidepressant interventions
315445
Reposted by Gregers Wegener
Altmetric @altmetric.com · 18/11/2024
We strongly suggest that academic publishers and other platforms that host research rapidly implement a Share to Bluesky button for their articles. Here's how: docs.bsky.app/docs/advance... #AcademicSky #HigherEd #Altmetrics
docs.bsky.app
Action Intent Links | Bluesky
Authors, websites, and apps can use action intent links to implement "Share on Bluesky" buttons, or similar in-app actions. Logged-in users will be directed to the corresponding action view in the Blu...
166113164573
Reposted by Gregers Wegener
Acta Neuropsychiatrica @actaneuropsych.bsky.social · 15/11/2024
Significant improvements in: ✅🌟attention consistency 🎯🔍target/non-target discrimination 🛑🚦inhibitory ctrl 🌟W/ gamma freq linked to attention/cog processing, findings highlight a promising path for addressing cognitive impairments across diverse conditions Access the paper at doi.org/10.1017/neu....
001
Reposted by Gregers Wegener
Acta Neuropsychiatrica @actaneuropsych.bsky.social · 15/11/2024
⚡Positive evidence on Transcranial alternating current stimulation (tACS) to neuropsychiatric conditions, as #dyslexia, #anxiety, #depression & #ADHD is beginning to accumulate Lee et al. explored the effects of gamma-frequency tACS applied to F4 and P4 regions. The results?⬇️
101